← All Accolade, INC filings

Accolade, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

ACCD
Accolade, INC
8-K: Accolade Stockholders Approve Merger with Transcarent
Accolade stockholders have approved the merger with Transcarent, paving the way for Accolade to become a privately held company.
ACCD
Accolade, INC
8-K: Transcarent to Acquire Accolade in $621 Million Deal, Creating Healthcare Platform Giant
Transcarent will acquire Accolade for $7.03 per share in cash, creating a combined healthcare platform with over 1,400 employer and payer clients.
ACCD
Accolade, INC
8-K: Accolade Reports Fiscal Q2 2025 Results, Nears Full-Year Profitability
Accolade announced its fiscal second quarter 2025 results, showing revenue growth and significant improvement in adjusted EBITDA, positioning the company for its first full year of profitability.
ACCD
Accolade, INC
8-K: Accolade, Inc. Holds 2024 Annual Meeting, Elects Directors and Ratifies Auditor
Accolade, Inc. held its 2024 Annual Meeting of Stockholders, electing three Class I directors, approving executive compensation on an advisory basis, and ratifying KPMG LLP as its independent auditor for the fiscal year ending February 28, 2025.
ACCD
Accolade, INC
8-K: Accolade Reports Strong First Quarter Results, Revenue Up 18%
Accolade, Inc. announced its fiscal first quarter 2025 results, showing an 18% increase in revenue and significant improvement in adjusted EBITDA.
ACCD
Accolade, INC
8-K: Accolade Reports Strong Q4 and Full Year 2024 Results, Projects Profitability
Accolade, Inc. announced its fiscal fourth quarter and full year 2024 results, highlighting significant revenue growth and a path to full-year profitability in 2025.